Roche's Xeloda, Sanofi-Aventis's Eloxatin/Eloxatine, and Yakult's Elplat Will

Drive Market to Treat the Disease, According to a New Report from Decision

Resources

    WALTHAM, Mass., Nov. 1 /PRNewswire/ -- Decision Resources, Inc., one of
 the world's leading research and advisory firms focusing on pharmaceutical and
 health care issues, finds that the drug market for the treatment of colorectal
 cancer will experience significant growth of 16.6% annually through 2009.
     The new Pharmacor report entitled Colorectal Cancer finds that the
 extension of Roche's Xeloda (capecitabine), Sanofi-Aventis's
 Eloxatin/Eloxatine (oxaliplatin), and Yakult's Elplat (oxaliplatin) into
 adjuvant therapy regimens will fuel market growth for cytotoxic agents in the
 treatment of operable colorectal cancer. The report also forecasts healthy,
 but more modest market growth of 6.6% annually during the second half of the
 study period, 2009 to 2014.
     "More aggressive adjuvant treatment of operable colorectal cancer will
 drive the sales of Xeloda, Eloxatin/Eloxatine, and Elplat, all of which are
 currently used to treat inoperable metastatic colorectal cancer," said Joanne
 Graham, Ph.D., analyst at Decision Resources, Inc. "Additionally, recent
 European approvals of Genentech/Roche's Avastin (bevacizumab) and
 ImClone/Bristol-Myers Squibb/Merck KGaA's Erbitux (cetuximab) will add to the
 already thriving market in the United States for biologicals that provide
 additional treatment options and extend overall survival for inoperable
 metastatic colorectal cancer."
 
     About Colorectal Cancer
     Colorectal cancer is the third most common form of cancer worldwide.
 Despite significant progress in its treatment over the past decade, colorectal
 cancer remains the second-leading cause of malignancy-related death in the
 United States.
 
     About Pharmacor from Decision Resources
     Pharmacor is a unique family of studies that assesses a host of market-
 impacting factors and analyzes the commercial outlook for drugs in research
 and development.
 
     About Decision Resources
     Decision Resources, Inc., (http://www.decisionresources.com) is a world
 leader in market research publications, advisory services, and consulting
 designed to help clients shape strategy, allocate resources, and master their
 chosen markets.
 
     All company, brand, or product names contained in this document may be
 trademarks or registered trademarks of their respective holders.
 
     For more information, contact:
     Elizabeth Marshall
     Decision Resources, Inc.
     781-296-2563
     emarshall@dresources.com
 
 

SOURCE  Decision Resources, Inc.